Venture rounds, IPOs, and mergers across health tech, medtech, and care delivery, with the amounts and investors from the filings.
FirstMark Capital led the Series A, joined by CVS Health Ventures and Valtruis. The New York company says it has more than 100,000 families on a waiting list and was picked for all four tracks of CMS's ACCESS Model.
The Fort Wayne, Ind., health system agreed to acquire Ovation Healthcare, a Brentwood, Tenn., shared-services company that works with more than 500 health care organizations. Terms were not disclosed.
Avidity Partners led the Series D for the cloud radiology software company, which says revenue grew 2.5 times in a year and that it is contracted to onboard more than 1,000 additional radiologists.
The deal adds BioReference's clinical, women's health, urology and corrections testing, more than 80 patient service centers and the 4Kscore prostate test, with up to $150 million more tied to 4Kscore sales.
Steris expects the maker of Pink Pad surgical positioning products to bring in about $245 million in 2026 revenue. It will fund the cash deal mainly with debt, backed by a $2 billion bridge commitment.
Healthier Capital, Crosslink Capital and Hercules Capital joined the Series E. Suki says its revenue doubled last year and sales to companies that embed its AI have grown more than tenfold in two years.
Existing investor BioStar Capital led the Series D, which MMI says brings its total funding to about $345 million. The company will spend it on U.S. and global sales of its Symani robot and on clinical studies.
Sequoia and First Round co-led an $8 million seed and Hummingbird led a $30 million Series A, TechCrunch reported. Healthleap's software flags inpatients for review; the company says it does not diagnose.
Andreessen Horowitz led the Series B, which brings the San Francisco company's funding to $152 million. Former Matrix general partner TJ Parker is now CEO, and Eli Lilly is among the investors.
Oak HC/FT led the Series A for Vitalize, which sells AI scheduling and capacity software to health systems. The company says labor makes up 50% to 60% of what hospitals spend to operate.
A Form D filed Oct. 5 shows the maker of the MIRA surgical robot sold $35.1 million of a planned $80.1 million offering, almost all of it from converted notes. The company has not announced the round.
Cook Medical led Zenflow's oversubscribed $52 million Series D and will be the exclusive U.S. distributor of the Zenflow Spring, an in-office implant for enlarged prostate that the FDA approved in December 2025.
SOFIE Biosciences runs 15 U.S. manufacturing sites with 21 cyclotrons and already makes GE HealthCare's Flyrcado tracer. GE HealthCare is buying it from Trilantic North America in an all-cash deal.
The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.